I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Congenital cataract (CC) refers to cataract observable at early year of life\[[@ref1]\] and is the leading cause of visual losses in children worldwide.\[[@ref2][@ref3]\] The incidence of CC varies from 0.01% to 0.06% in developed countries\[[@ref4]\] to 0.05--0.15% in less developed areas of the world.\[[@ref2][@ref3][@ref5][@ref6]\] CC can occur in isolation forms (nonsyndromic CC) or as part of a syndrome of ocular or systemic anomalies (syndromic CC).\[[@ref7]\] Major causing factors of CC include metabolic disorders, intrauterine infectious, and genetic defects (chromosomal abnormalities or gene defects). Moreover, approximately 8.3--25.0% of the CC cases are thought to have a genetic basis of etiology, a majority of which are Mendelian diseases caused by monogenic mutations.\[[@ref8][@ref9]\]

CC is a group of clinically and genetically heterogeneous diseases. Clinically, in addition to other abnormalities in syndromic CC, cataract itself includes a variety of morphologies, such as sutural, pulverulent, whole lens, nuclear, lamellar (also referred to as perinuclear), cortical, polar, cerulean, coralliform, and others.\[[@ref9][@ref10]\] Genetically, over 110 genes have been found associated with CC,\[[@ref11]\] including more than 20 genes involved in nonsyndromic CC (hitherto the initial of the study).\[[@ref9]\] Inherited patterns of nonsyndromic CC includes autosomal dominant (AD), autosomal recessive, and X-linked dominant patterns, with AD as the most common forms.\[[@ref1][@ref10]\] Of the more than 29 known nonsyndromic CC genes, at least 22 are involved in autosomal dominant congenital cataract (ADCC), including *BEST1*, *BFSP2*, *CHMP4B*, *CRYAA*, *CRYAB*, *CRYBA1*, *CRYBA4*,*CRYBB1*, *CRYBB2*, *CRYBB3*, *CRYGC*, *CRYGD*, *CRYGS*, *EPHA2*, *GJA3*, *GJA8*, *HSF4*, *MAF*, *MIP*, *PITX3*, *SLC16A12*, and *VIM*. Most of the genes mainly involve in specific processes in lens development, intercellular communication in the lens, or the organization of lens fibers.\[[@ref9]\] Of note, the relation between cataract phenotypes and mutant genes is even more complex for nonsyndromic CC, i.e., mutations in different genes can cause similar cataracts phenotypes, mutations in a single gene can cause different types of cataracts, and one single mutation in a gene can cause different cataract phenotypes in patients.

Identifying the precise genetic cause of CC is essential for providing accurate diagnostics for medical management, prognostics, and recurrence risk counseling for the patient and family.\[[@ref12]\] However, due to the highly clinical and genetic heterogeneity, clinical genetic diagnostic practice of CC, especially for nonsyndromic CC, is greatly limited with the traditional sequencing method which sequences a few candidate genes at each time. Despite this, recently, the next generation sequencing (NGS) combined with targeted genomic enrichment has proved to be a cost-effective resolution to the genetic test of genetically heterogeneous diseases and provide a new opportunity for genetic diagnostics of CC.

In this study, we performed parallel sequencing of 45 CC genes by combined NGS and targeted genomic enrichments to determine the genetic mutations in a three-generation Chinese family with congenital nuclear cataracts. We identified a novel c.426_440delGCTGGAGGGGACCCT in *GJA8* that segregates with the disease phenotype in the family and evaluated potential pathogenicity of the deletion and modeled the functional impacts of the deletion on the structure of the connexin 50 (Cx50) protein. Our result demonstrates that the targeted gene sequencing using NGS can be used as an effective tool for molecular diagnosis of CC.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Participants recruitment, blood sampling, and DNA extraction {#sec2-1}
------------------------------------------------------------

This study was approved by the Institutional Review Boards of Beijing Genomic Institute (BGI)-Shenzhen. Nine members of a three-generation Chinese family from Guangdong with ADCCs were recruited in this study \[[Figure 1](#F1){ref-type="fig"}\]. Careful ophthalmological examinations and hospital medical record reviews were performed for each affected member to confirm the clinical diagnosis. After obtained written informed consent, peripheral venous blood samples were collected for all participants. Genomic DNA was extracted using a QIAamp DNA Blood MiNi kit (Qiagen, Germany).

![Pedigree and mutation analysis. (a) Pedigree of a three-generation Chinese family with congenital cataracts. The proband is indicated with an arrow. Squares and circles symbolize male and female individual, respectively. Black symbol indicates cataract affected status and white symbol indicates unaffected status. (b) DNA sequence chromatogram analysis. DNA sequence chromatograms of the unaffected members (top) and affected members (bottom) in the pedigree. Fifteen bases deletion in exon 2 causes a conservative deletion of LEGTL from codon 143--147 (p.143_147del). (c) Evolutionary sequence conservation analysis. Multiplex sequence alignment of connexin 50 from different species reveals that codon 143--147, where the mutation (p.143_147del) occurred, is located within a highly conserved region. (d) Allelic spectrum of reported disease-associated mutations. Schematic diagram of genomic structure of human GJA8 gene and allelic spectrum of diseases mutations are shown. The identified mutation in this study is marked with red line. CL (C1/C2/C3): cytoplasmic loop domain; TM: transmembrane domain; E1:extracellular domain 1; E2: extracellular domain 2.](CMJ-129-860-g001){#F1}

Capture probes design, targeted capture, and next generation sequencing {#sec2-2}
-----------------------------------------------------------------------

Forty-five genes implicated in the CC, including 29 nonsyndromic cataract genes (*AGK*, *BEST1*, *BFSP1*, *BFSP2*, *CHMP4B*, *CRYAA*, *CRYAB*, *CRYBA1*, *CRYBA4*, *CRYBB1*, *CRYBB2*, *CRYBB3*, *CRYGC*, *CRYGD*, *CRYGS*, *EPHA2*, *FYCO1*, *GJA3*, *GJA8*, *HSF4*, *P3H2*, *LIM2*, *MAF*, *MIP*, *NHS*, *PITX3*, *SLC16A12*, *TDRD7*, and *VIM*) and 16 syndromic cataract genes (*ABHD12*, *CNBP*, *CTDP1*, *EYA1*, *FTL*, *GALK1*, *GCNT2*, *GFER*, *GJA1*, *JAM3*, *OPA3*, *PAX6*, *RAB3GAP2*, *SIL1*, *SIX6*, and *SLC33A1*), were collected from careful literature and database search. The 45 genes selected contain almost all of the genes related to CC.\[[@ref1][@ref13]\] Moreover, genes related to ADCC, which are interested, were all included. Targeted sequencing capture DNA Probes were designed for exons and the flanking 30 bp intronic sequences using the Nimblegen SeqCap EZ Choice system (Roche NimbleGen, Madison, WI, USA). Targeted sequences capture and sequencing library preparation were performed as previously described.\[[@ref14]\] Paired-end sequencing (PE100) was performed on the Illumina HiSeq2000 platform (Illumina, San Dieago, CA, USA).

Short-reads mapping, variant detection, and annotation {#sec2-3}
------------------------------------------------------

After filtering of reads of low-quality and potential adaptor contamination,\[[@ref15]\] the clean reads were mapped to the reference human genome (hg19) using BWA software package (Burrows Wheeler Aligner <http://sourceforge.net/projects/bio-bwa/>).\[[@ref16]\] Single nucleotide variants (SNVs) were identified using SOAPsnp software (<http://soap.genomics.org.cn/>),\[[@ref17]\] and small insertion and deletions (InDels) were identified using the GATK InDel Genotyper (The Genome Analysis Toolkit, <http://www.broadinstitute.org/gsa/wiki/index.php/>).\[[@ref18]\] The variants were annotated using a BGI in-house developed annotation pipeline.

Sequence conservation analysis and estimation of deleteriousness {#sec2-4}
----------------------------------------------------------------

Multiple alignments of Cx50 protein sequences between species were directly obtained from the UCSC genome browser home (<http://genome.ucsc.edu/>) and realigned with the Molecular Evolutionary Genetics Analysis (MEGA 6.06, <http://www.megasoftware.net>). The online free tool Combined Annotation-Dependent Depletion (CADD, <http://cadd.gs.washington.edu/>),\[[@ref19]\] a newly developed framework that integrates diverse annotations into a single quantitative score (C-score) to measure the deleteriousness of SNVs and small InDels, was used to evaluate the pathogenicity of the deletion.

Construction of connexin 50 three-dimensional structure model {#sec2-5}
-------------------------------------------------------------

In the absence of Cx50 experimental structures, the comparative modeling methods based on high sequence identity can be employed to predict the Cx50 protein structure, which can subsequently be used to aid in the understanding of protein functional mechanisms. The amino acid sequences of wild type (WT) Cx50 and mutant Cx50 above were used to perform the sequence similarity searches using the NCBI BLAST in SWISS-MODEL server (<http://swissmodel.expasy.org/>).\[[@ref20]\] The newly disclosed structure of human Cx26 (Protein Data Bank \[PDB\] code: 2ZW3)\[[@ref21]\] was selected as the template to construct the Cx50 structure that shares a sequence identity of 57% with WT Cx50 sequence. The modeling result is shown in Supplementary Figure 1.

###### 

(a and b) The overall structure of the connexin 50 chennal model in hydrophocipy surface representation.

###### 

Click here for additional data file.

The system of generating lipid bilayer structures as well as membrane-bound protein structures, CHARMM-GUI Lipid Builder\[[@ref22]\] was used to build a Cx50 protein/membrane complex for molecular dynamics (MD) simulations. The Cx50 models (WT and mutant) were inserted into a fully hydrated palmitoyl-oleyl phosphatidylcholine (POPC) lipid bilayer of 400 molecules (set 200 on the lower leaflet and 200 on the upper leaflet) \[Supplementary Figure 2\]. The water model used was three-point model (TIP3P). To remove the net charge of the system, an ionic concentration of 150 mM KCl by transmuting random water molecules into K^+^ and Cl^−^ was added as counterions.

###### 

The illustration of homo-6-mer connexin 50 protein/membrane complex models.

###### 

Click here for additional data file.

Molecular dynamics simulation {#sec2-6}
-----------------------------

MD simulations were carried out using the parallel MD program GROMACS 4.6.5 for all protein molecules, POPC lipid molecules, and ions along with the TIP3P model for water molecules. A cutoff of 10 Å for van der Waals interactions was imposed. The particle mesh Ewald\[[@ref23]\] technique with a short-range cutoff of 10 Å was employed to calculate long-range electrostatic forces. The periodic boundary conditions were introduced on all simulations with an integration time step of 2 fs to employ a multiple time stepping algorithms. The simulations were equilibrated as an NPT ensemble, using the Langevin dynamics\[[@ref24]\] method to keep the pressure at 1 atm, and the temperature was maintained at 303 K using Langevin dynamics with a very weak friction coefficient. The MD simulation protocol is detailed description as follows: To remove the largest strains in the system, all simulation systems were first subjected to 5000 cycles of steepest descent, while position restraints were applied to the residues of the Cx50 models as well as the molecules of POPC lipid bilayer. Afterward, MD with position restraints applied only to the protein was performed for 0.1 ns. All the positional restraints were eliminated in the third round, and the systems were allowed to preequilibrate for 5 ns. The production simulations were finally conducted for 10 ns for all systems.

Sanger sequencing {#sec2-7}
-----------------

Polymerase chain reaction (PCR) primer sets were designed to sequence the first exons of *MAF*,*EPHA2*, and *NHS* genes not covered in targeted sequencing, as well as to analyze the segregation of the *GJA8* deletion in the family \[[Supplementary Table 1](#T1){ref-type="table"}\]. The PCR amplification was conducted in a 25 μl reaction volume containing 1X PCR buffer with 1.5 mM MgCl~2~, 200 μM each dNTP, 0.25 U Taq DNA polymerase (Takara, Dalian, China), 1.5 μM primers, and 50 ng genomic DNA. The PCR condition was 94°C for 4 min, 35 cycles of 94°C for 30 s, 59°C for 30 s, and 72°C for 45 s, and a final 72°C for 10 min. The PCR products were purified and sequenced at both ends on an ABI3730xl DNA sequencer (PE Applied Biosystems, Forest City, CA, USA).

###### 

Primers for PCR amplification of exons of candidate genes and the size of the PCR products

  Gene      Exon   Primers sequence (5'--3')   Fragment size (bp)
  --------- ------ --------------------------- --------------------
  *GJA8*    2      F\*-GTGCACTACGTCCGCATG      298
                   R^†^-CGAAGCAGTCCACCACATTG   
  *MAF*     1      F-AGCTGGTGACCATGTCTGTG      407
                   R-AGAACTAGCAAGCCCACACC      
                   F-AACTGGCAATGAGCAACTCC      548
                   R-GTGGTGGTGGTGGTGGTAGT      
                   F-GAGCGAGGGAGCACATTG        352
                   R-CCGGTTCCTTTTTCACTTCA      
                   F-CCGCACTACCACCACCAC        432
                   R-CTGGTTCTTCTCCGACTCCA      
  *EPHA2*   1      F-GACCAAGCTGAAACCGCTTA      684
                   R-TACCAGGCTCAGAGATCCCT      
  *NHS*     1      F-AGGCAAGGTGAGCAGAGAAG      764
                   R-CGCAGAAACCCATAGCCTG       

\*F: Forward primers; ^†^R: Reverse primers; PCR: Polymerase chain reaction.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Pedigree and clinical features {#sec2-8}
------------------------------

The family includes 5 affected and 4 unaffected members in a three-generation pedigree \[[Figure 1a](#F1){ref-type="fig"}\]. The transmission of cataract from the female founder (also the proband) to four out of five of her offsprings with both genders supports a dominant inheritance pattern of the lens diseases in the family. All affected members have nuclear cataracts with no other ocular or systemic abnormalities \[[Figure 1a](#F1){ref-type="fig"} and [Table 1](#T2){ref-type="table"}\]. The presences of cataracts at birth were confirmed by hospital records, and nonsyndromic CC was diagnosed for all affected members.

###### 

Summary of clinical evaluations for the Chinese cataract family

  Member   Gender   Age at onset   Age at diagnosis   Cataract phenotypes   Other abnormalities   Diagnosis
  -------- -------- -------------- ------------------ --------------------- --------------------- -----------------------------
  I:1      Male     No             65                 Normal                No                    Normal
  I:2      Female   No             67                 Normal                No                    Normal
  II:1     Male     No             48                 Normal                No                    Normal
  II:2     Female   On birth       42                 Nuclear, bilateral    No                    Congenital nuclear cataract
  III:1    Male     On birth       13                 Nuclear, bilateral    No                    Congenital nuclear cataract
  III:2    Female   On birth       22                 Nuclear, bilateral    No                    Congenital nuclear cataract
  III:3    Female   On birth       25                 Nuclear               No                    Congenital nuclear cataract
  III:4    Female   On birth       15                 Nuclear               No                    Congenital nuclear cataract
  III:5    Female   On birth       18                 Normal                No                    Normal

Targeted sequencing of 45 cataract genes {#sec2-9}
----------------------------------------

The coding sequence-exons and adjacent intronic sequences of 45 cataract genes, consisting of 366 exons and 63003 bp, were captured and sequenced for the proband DNA (see Materials and Methods). A total of 224,437 clean reads in 15,940,353 bp length (or \~15.94 Mb data) mapped to targeted regions were generated on Hiseq2000 \[[Table 2](#T3){ref-type="table"}\]. This formed a mean coverage depth of 218-fold on the targeted regions of the 45 cataract genes, with a general sequence coverage rate of 99.23% and a high-quality genotype assignment (\>×10) rate of 97.29% \[[Table 2](#T3){ref-type="table"}\]. The uncovered targeted regions were all the first coding exons with extreme GC content \[mean CC% \>69%, [Supplementary Table 2](#T4){ref-type="table"}\]. Supplementary sequencing was performed to cover the sequences of three of the uncovered first coding exons (see Materials and Methods) while the others were excluded for the analysis considering a syndromic form or a nondominant inheritance pattern of cataracts associated with the related genes \[[Supplementary Table 2](#T4){ref-type="table"}\].

###### 

Summary statistics for targeted sequencing of 45 cataracts genes in the proband

  Gene         OMIM diseases             Transcript       Number of coding exons   Sizes (bp)   Sequencing depth (X)   Coverage rate (%)            
  ------------ ------------------------- ---------------- ------------------------ ------------ ---------------------- ------------------- -------- --------
  *ABHD12*     \#612674 (AR, Sa)         NM_015600.4      13                       1215         192                    99.26               84.28    84.28
  *AGK*        \#614691 (AR, NSa)        NM_018238.3      16                       1269         270                    100.00              100.00   100.00
  *BEST1*      \#193220 (AD, NS)         NM_001139443.1   9                        1815         320                    100.00              100.00   100.00
  *BFSP1*      \#611391 (AR, NS)         NM_001195.3      8                        1998         272                    99.95               97.00    85.44
  *BFSP2*      \#611597 (AD, NS)         NM_003571.2      7                        1248         164                    100.00              100.00   100.00
  *CHMP4B*     \#605387 (AD, NS)         NM_176812.4      5                        675          214                    100.00              100.00   100.00
  *CNBP*       \#602668 (AD, S)          NM_001127192     4                        513          155                    97.87               94.92    93.94
  *CRYAA*      \#604219 (AD, NS)         NM_000394.2      3                        522          154                    100.00              100.00   100.00
  *CRYAB*      \#613763 (AD/AR, NS)      NM_001885.1      3                        528          313                    100.00              100.00   100.00
  *CRYBA1*     \#600881 (AD, NS)         NM_005208.4      6                        648          245                    100.00              100.00   100.00
  *CRYBA4*     \#610425(AD/AR, NS)       NM_001886.2      6                        591          141                    100.00              100.00   100.00
  *CRYBB1*     \#611544 (AD/AR, NS)      NM_001887.3      6                        759          145                    100.00              100.00   100.00
  *CRYBB2*     \#601547 (AD, NS)         NM_000496.2      6                        618          194                    100.00              100.00   100.00
  *CRYBB3*     \#609741 (AD/AR, NS)      NM_004076.3      6                        636          144                    100.00              100.00   100.00
  *CRYGC*      \#604307 (AD, NS)         NM_020989.3      3                        525          179                    100.00              100.00   100.00
  *CRYGD*      \#115700 (AD, NS)         NM_006891.3      3                        525          179                    100.00              100.00   100.00
  *CRYGS*      \#116100 (AD, NS)         NM_017541.2      3                        537          364                    100.00              100.00   100.00
  *CTDP1*      \#604168 (AR, S)          NM_004715.4      13                       2886         126                    92.31               89.12    89.12
  *EPHA2*      \#116600 (AD, NS)         NM_004431.3      17                       2931         150                    100.00              97.10    97.10
  *EYA1*       \#113650 (AD, S)          NM_000503.4      18                       1779         314                    100.00              100.00   100.00
  *FTL*        \#600886 (AD, S)          NM_000146.3      4                        528          131                    100.00              100.00   100.00
  *FYCO1*      \#610019 (AR, NS)         NM_024513.3      18                       4437         194                    100.00              100.00   100.00
  *GALK1*      \#230200 (AR, S)          NM_000154.1      8                        1179         80                     100.00              100.00   100.00
  *GCNT2*      \#110800 (AR, S)          NM_145649.4      5                        1209         421                    100.00              100.00   100.00
  *GFER*       \#613076 (AR, S)          NM_005262.2      3                        618          120                    100.00              95.63    73.46
  *GJA1*       \#257850 (AR, S)          NM_000165.3      2                        1149         371                    100.00              100.00   100.00
  *GJA3*       \#601885 (AD, NS)         NM_021954.3      2                        1308         127                    100.00              100.00   100.00
  *GJA8*       \#116200 (AD, NS)         NM_005267.4      2                        1302         270                    100.00              100.00   100.00
  *HSF4*       \#116800 (AD, NS)         NM_001040667.2   15                       1479         125                    100.00              100.00   98.24
  *JAM3*       \#613730 (AR, S)          NM_032801.4      9                        933          275                    100.00              100.00   100.00
  *LEPREL1*    \#614292 (AR, NS)         NM_018192.3      15                       2127         191                    100.00              99.76    92.57
  *LIM2*       \#615277 (AR, NS)         NM_030657.3      5                        648          166                    100.00              100.00   100.00
  *MAF*        \#610202 (AD, NS)         NM_005360.4      2                        1212         100                    79.04               76.32    73.10
  *MIP*        \#615274 (AD, NS)         NM_012064.3      4                        792          204                    100.00              100.00   100.00
  *NHS*        \#302200 (XD, NS and S)   NM_198270.2      8                        4893         355                    97.06               95.26    90.88
  *OPA3*       \#165300 (AD, S)          NM_001017989.2   2                        543          75                     100.00              100.00   100.00
  *PAX6*       \#106210 (AD, S)          NM_001258462.1   14                       1311         283                    100.00              100.00   100.00
  *PITX3*      \#610623 (AD, NS)         NM_005029.3      4                        909          59                     100.00              100.00   100.00
  *RAB3GAP2*   \#212720 (AR, S)          NM_012414.3      35                       4182         327                    100.00              100.00   100.00
  *SIL1*       \#248800 (AR, S)          NM_001037633.1   11                       1386         193                    100.00              100.00   100.00
  *SIX6*       \#212550 (AR, S)          NM_007374.2      2                        741          206                    100.00              100.00   100.00
  *SLC16A12*   \#612018 (AD, NS)         NM_213606.3      8                        1551         334                    100.00              100.00   100.00
  *SLC33A1*    \#614482 (AR, S)          NM_004733.3      6                        1650         391                    100.00              100.00   100.00
  *TDRD7*      \#613887 (AR, NS)         NM_014290.2      17                       3297         368                    100.00              100.00   100.00
  *VIM*        \#116300 (AD, NS)         NM_003380.3      10                       1401         201                    100.00              100.00   100.00
                                                                                                                                                    
  Total                                                   366                      63,003       218                    99.23               98.43    97.29

OMIM: Online Mendelian Inheritance in Man; AR: Autosomal recessive; AD: Autosomal dominant; XD: X-linked dominant; S: Syndromic; NS: Non-syndromic.

###### 

Gene (exons) with poor sequencing coverage and the associated diseases

  Gene       Related cataracts                                                                        Exon   Size (bp)   GC content (%)   Sequencing depth (x)   Coverage rate (%)   Uncovered sequences          
  ---------- ---------------------------------------------------------------------------------------- ------ ----------- ---------------- ---------------------- ------------------- --------------------- ------ -------
  *EPHA2*    \#116600, cataract 6, multiple types, AD                                                 EX1    240         74.17            29.70                  54.12               c.1_85                85     2.14
  *BFSP1*    \#611391, cataract 33, AR                                                                EX1    417         76.13            100.89                 99.73               c.1_377               377    18.87
  *ABHD12*   \#612674, polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, AR   EX1    470         78.13            96.43                  95.29               c.1_191               191    15.72
  *MAF*      \#610202, cataract, pulverulent or cerulean, with or without microcornea, AD             EX1    1941        69.65            72.14                  77.28               c.1_1118              1118   42.24
  *CTDP1*    \#604168, congenital cataracts, facial dysmorphism, and neuropathy, AR                   EX1    461         78.09            5.30                   29.30               c.1_314               314    8.37
  *NHS*      \#302200, cataract 40, X-linked, XD                                                      EX1    903         70.99            79.55                  74.51               c.1_565               565    6.45

AR: Autosomal recessive; AD: Autosomal dominant; XD: X-linked dominant.

Identification of potential causal mutation {#sec2-10}
-------------------------------------------

Mapped against the human reference genome sequences, a total of 43 variants, including forty substitutes and 3 small InDels, were identified on the 45 genes \[[Table 3](#T5){ref-type="table"} and [Supplementary Table 3](#T6){ref-type="table"}\]. A vast majority of these variants (29/43) were either synonymous substitutes or from untranslated regions \[[Table 3](#T5){ref-type="table"}\]. These variants are thought to be of less potentially pathogenicity, and we put them aside first. Of the remaining variants with potential function importance (including ten nonsynonymous, 3 splice acceptor and donor site mutations, and 1 coding InDels), only the heterozygous in-frame coding on *GJA8* was novel meeting the criteria as nonpolymorphic with an allele frequency \<5% in any of the single nucleotide polymorphism database, HapMap, or 1000 genome project database. Multiplex protein sequences alignment shows that the deleted sequence was evolutionarily conserved among ten species with high-quality reference genome sequences available on UCSC genomes database \[[Figure 1c](#F1){ref-type="fig"}\]. More importantly, the deletion was found in full cosegregation with cataract phenotypes in Sanger sequencing analysis of the mutation in the pedigree \[Figure [1a](#F1){ref-type="fig"} and [1b](#F1){ref-type="fig"}\] but was not detected in 1100 BGI in-house control exomes \[[Supplementary Table 3](#T6){ref-type="table"}\], genetically suggesting a potential pathogenic role of the deletion. Intriguingly, the deletion was not detected on both unaffected parents of the proband in Sanger sequencing validation analysis \[Figure [1a](#F1){ref-type="fig"} and [1b](#F1){ref-type="fig"}\], supporting a *de novo* occurrence of the deletion in the proband.

###### 

Summary statistics for variants detected in targeted sequencing of 45 cataract genes in the proband

  Mutation type                                                               Number
  --------------------------------------------------------------------------- --------
  SNVs                                                                        40
   NS                                                                         10
   Synonymous                                                                 28
   SS                                                                         2
  InDels                                                                      3
   Coding (I)                                                                 1
   SS                                                                         1
   UTR                                                                        1
  NS/SS/I                                                                     14
   Allele frequency ≤0.05 in dbSNP (snp137), HapMap or 1000 genomes project   2
   Allele frequency ≤0.05 in 1100 BGI in-house control exomes                 1
   Frequency ≤0.05 in either                                                  1

NS: Nonsynonymous; SS: Spicing sites; UTR: Untranslated regions; dbSNP: Single nucleotide polymorphism database; BGI: Beijing Genomic Institute; SNVs: Single nucleotide variants; InDels: Insertion and deletions.

The pathogenicity of the deletion was further evaluated with CADD. The C-score of 15.52 supports a pathogenic role of the deletion (mutations with C-score \>15 were supposed to be pathogenic).\[[@ref19]\]

###### 

Variants detected in the 45 cataract genes in the proband

  Gene         Transcript     Variant                          Hom/Het   Reads           Mutation type   Gene region   Functional region   rsID\*        Frequency in dbSNP^†^   Frequency in HapMap^‡^   Frequency in 1000 genomes^§^   Frequency in 1100 exomes^\|\|^
  ------------ -------------- -------------------------------- --------- --------------- --------------- ------------- ------------------- ------------- ----------------------- ------------------------ ------------------------------ --------------------------------
  *SLC16A12*   NM_213606      c.49 T\>G                        Het       C99/103A;202    SNV             CDS1          Missense            rs3740030     0.163                   0.38                     0.1538                         0.3641
  *PITX3*      NM_005029      c.285 C\>T                       Het       A25/22G;47      SNV             CDS2          Synonymous          rs2281983     0.43                    0                        0.424                          0.3795
  *BEST1*      NM_001139443   c.39 C\>A                        Hom       A142;142        SNV             CDS1          Synonymous          rs1109748     0.075                   0.547                    0.1474                         0.5333
  *BEST1*      NM_001139443   c.1428 T\>C                      Hom       C249/1T;250     SNV             CDS8          Synonymous          rs1800009     0                       0                        0.3553                         0.7638
  *JAM3*       NM_032801      c.978−3 T\>C                     Het       C106/142T;248   SNV             Intron7       Splice              rs610382      0.498                   0.434                    0.402                          0.4342
  *GJA3*       NM_021954      c.1017 G\>A                      Het       T41/19C;60      SNV             CDS1          Synonymous          rs11617415    0.371                   0                        0.3736                         0.1949
  *GJA3*       NM_021954      c.895 C\>A                       Hom       T103;103        SNV             CDS1          Missense            rs968566      0.966                   0                        0.967                          1
  *CNBP*       NM_001127192   c.156 C\>T                       Het       A108/86G        SNV             CDS2          Synonymous          rs4303883     0.381                   0.277                    0.2115                         0.2308
  *CTDP1*      NM_004715      c.978 G\>A                       Het       A127/122G;249   SNV             CDS7          Synonymous          rs599554      0.326                   0.175                    0.283                          0.1128
  *CTDP1*      NM_004715      c.1461 G\>A                      Het       A54/28G;82      SNV             CDS8          Synonymous          rs2126082     0.304                   0                        0.2756                         0.1026
  *CTDP1*      NM_004715      c.2817 T\>C                      Hom       C33;33          SNV             CDS13         Synonymous          rs626169      0.846                   0.993                    0.8672                         0.9949
  *EPHA2*      NM_004431      c.2874 C\>T                      Het       A42/49G;91      SNV             CDS17         Synonymous          rs3754334     0.355                   0.226                    0.326                          0.241
  *EPHA2*      NM_004431      c.1983 C\>T                      Het       A77/94G;171     SNV             CDS11         Synonymous          rs10907223    0.267                   0.206                    0.2024                         0.1949
  *EPHA2*      NM_004431      c.987 C\>T                       Het       A27/35G;62      SNV             CDS5          Synonymous          rs2230597     0.433                   0.184                    0.4158                         0.2564
  *BFSP1*      NM_001195      c.1749 A\>G                      Hom       C250;250        SNV             CDS8          Synonymous          rs6080718     0                       0.358                    0.5403                         0.4154
  *BFSP1*      NM_001195      c.1500 G\>A                      Het       T109/141C;250   SNV             CDS8          Synonymous          rs6136118     0.431                   0.453                    0.4295                         0.4615
  *BFSP1*      NM_001195      c.1033 G\>A                      Het       T102/108C;210   SNV             CDS7          Missense            rs6080719     0.378                   0.489                    0.3608                         0.4564
  *BFSP1*      NM_001195      c.90 G\>A                        Het       T2/3C;5         SNV             CDS1          Synonymous          snp105        0                       0                        0                              0
  *ABHD12*     NM_015600      c.1068 T\>C                      Hom       G211;211        SNV             CDS12         Synonymous          rs10966       0.31                    0                        0.3581                         0.516
  *CRYAA*      NM_000394      c.6 C\>T                         Hom       T149;149        SNV             CDS1          Synonymous          rs872331      0.276                   0.03                     0.315                          0.2278
  *CRYBB3*     NM_004076      c.337 C\>G                       Hom       G144;144        SNV             CDS4          Missense            rs9608378     0.456                   0.867                    0.4908                         0.8718
  *CRYBB2*     NM_000496      c.449+9 G\>A                     Hom       A96;96          SNV             Intron5       Splice              rs4049505     0                       0                        0.6145                         0.9026
  *CRYBB2*     NM_000496      c.483 G\>A                       Het       A67/79G;146     SNV             CDS5          Synonymous          rs8140949     0.412                   0                        0.3819                         0.4923
  *CRYBA4*     NM_001886      c.171 T\>C                       Hom       C128;128        SNV             CDS3          Synonymous          rs5761637     0.844                   0                        0.848                          0.9949
  *CRYGD*      NM_006891      c.285 A\>G                       Hom       C249;249        SNV             CDS3          Synonymous          rs2305430     0.626                   0.453                    0.6392                         0.3846
  *CRYGD*      NM_006891      c.51 T\>C                        Het       G37/40A;77      SNV             CDS2          Synonymous          rs200375285   0                       0.518                    0.435                          0.2974
  *FYCO1*      NM_024513      c.3924 C\>T                      Hom       A194;194        SNV             CDS13         Synonymous          rs1463680     0.739                   0.956                    0.7473                         0.8114
  *FYCO1*      NM_024513      c.2036 C\>T                      Het       A68/68G;136     SNV             CDS7          Missense            rs3796375     0.489                   0.519                    0.4203                         0.3808
  *FYCO1*      NM_024513      c.1335 G\>A                      Het       T101/140C;241   SNV             CDS7          Synonymous          rs3796376     0.315                   0.562                    0.3168                         0.3203
  *FYCO1*      NM_024513      c.962 G\>C                       Het       G60/84C;144     SNV             CDS7          Missense            rs3733100     0.499                   0.489                    0.457                          0.3879
  *FYCO1*      NM_024513      c.749 G\>A                       Hom       T219;219        SNV             CDS7          Missense            rs4683158     0                       1                        0.8498                         0.8932
  *FYCO1*      NM_024513      c.267 C\>A                       Hom       T249;249        SNV             CDS3          Synonymous          rs4682801     0.622                   1                        0.6667                         0.8114
  *BFSP2*      NM_003571      c.603 G\>A                       Het       A84/129G;213    SNV             CDS3          Synonymous          rs2276737     0.495                   0.519                    0.4277                         0.4513
  *SLC33A1*    NM_004733      c.512 A\>G                       Het       C113/137T;250   SNV             CDS1          Missense            rs3804769     0.174                   0.226                    0.1722                         0.2278
  *EYA1*       NM_172058      c.1755 T\>C                      Het       G51/42A;93      SNV             CDS16         Synonymous          rs10103397    0.497                   0.407                    0.4267                         0.388
  *EYA1*       NM_172058      c.1278 C\>T                      Het       A135/115G;250   SNV             CDS12         Synonymous          rs4738118     0.399                   0.455                    0.2811                         0.4614
  *EYA1*       NM_172058      c.813 A\>G                       Hom       C248;248        SNV             CDS7          Synonymous          rs1445398     0.034                   0.224                    0.0632                         0.1747
  *TDRD7*      NM_014290      c.33 A\>G                        Hom       G249;249        SNV             CDS1          Synonymous          rs1381532     0.322                   0.299                    0.3114                         0.2811
  *TDRD7*      NM_014290      c.449 T\>C                       Hom       C243/5T;248     SNV             CDS3          Missense            rs2045732     0.322                   0.281                    0.3114                         0.2776
  *NHS*        NM_198270      c.3955 T\>C                      Het       C128/121T;249   SNV             CDS6          Missense            rs3747295     0.469                   0.25                     0.1374                         0.1692
  *MAF*        NM_005360      c.--1637\_−1639 delGGC           Het       W34/M14;48      Deletion        5-UTR         5-UTR               \_            No_frequency            Not_in_HapMap            0                              0.4744
  *GJA8*       NM_005267      c.426_440 delGCTG GA GGGGACCCT   Het       W169/M78;247    Deletion        CDS1          CDS                 \_            No_frequency            Not_in_HapMap            0                              0
  *RAB3GAP2*   NM_012414      c.812−6 delT                     Het       W67/M68;135     Deletion        Intron9       Splice              \_            No_frequency freq       Not_in_HapMap            0                              0.3154

\*NCBI dbSNP ID; ^†^Allele frequency in NCBI dbSNP; ^‡^Allele frequency in HapMap; ^§^Allele frequency in 1000 genome project; ^\|\|^Allele frequency in BGI in-house control exomes. dbSNP: Single nucleotide polymorphism database; SNV: Single nucleotide variant; UTR: Untranslated regions; CDS: Coding sequence; BGI: Beijing Genomic Institute.

This novel heterozygous deletion was concerned with a sequence deletion of 5 amino acids (or 15 bp) at the intracellular loop domain (cytoplasmic loop \[CL\]) of the Cx50 protein (or *GJA8*) \[[Figure 1d](#F1){ref-type="fig"}\], which connects two transmembrane domains and was suspected to serving as binding sites of Ca^2+^/CaM in gap junction channel function.\[[@ref25][@ref26]\] Mutations on *GJA8* have caused multiplex ADCCs (Cataract 1, multiple types, OMIM\#116200) including nuclear cataracts.

Potential functional impact of the deletion {#sec2-11}
-------------------------------------------

To illustrate the dysfunction of Cx50 mutant, we performed MD simulation. At first, the best hit in PDB of Cx50 protein was used to predict the three-dimensional structure (see Materials and Methods). The overall structure of Cx50 represents a typical channel protein that contains a hydrophobic surface and hydrophilic channel \[Supplementary Figure 1\]. Then, the protein/membrane complex with lipid bilayer system and water was built to simulate the environment of Cx50 in cell. Both WT and mutant of Cx50 were inserted into the lipid bilayer system \[[Figure 2a](#F2){ref-type="fig"} and Supplementary Figure 2\]. Finally, MD simulation was performed on both models (see Methods). As shown in [Figure 2b](#F2){ref-type="fig"}, WT protein molecules were very stable in our system. However, the mutant molecules were more dynamic and the root-mean-square deviation increased when mutant molecules stay in the system for a longer time. Thus, the mutant Cx50 becomes unstable in the simulated system, which may also happen in real cellular environment.

![Molecular dynamics simulation. (a) The illustration of mono connexin 50 protein/membrane complex models. The blue circle represents the lost region in connexin 50 mutant. (b) Simulation of molecular dynamics. The black curve denotes the structure dynamics of wild type and the red curve denotes mutants. X-axis is the time of simulation and Y-axis is the root-mean-square deviation of atoms.](CMJ-129-860-g002){#F2}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

The lens of human eye is an avascular structure, and gap junction channels encoded by Cxs function as the passage of intercellular transport of the ions and low molecular weight biomolecules. Cx50 (*GJA8*) and Cx46 (*GJA3*) are the major components of mammalian lens fiber cells, and mutations of these two genes account for approximately 20% of nonsyndromic familial cataract cases.\[[@ref7]\] The typical structure of Cx includes a cytoplasmic N-terminal domain (NT), four transmembrane domains (TM1 to TM4), two extracellular loops (E1 and E2), a CL between TM2 and TM3, and a C-terminal domain (CT). In this study, we identified a novel in-frame deletion of 15 bp in the coding region of *GJA8* gene (c.426_440delGCTGGAGGGGACCCT) associated with CCs in a three-generation Chinese family by targeted genes sequencing.

Several lines of evidence support a pathogenic role of the deletion. First, the deletion was concerned with an in-frame deletion of 5 amino acids within a highly evolutionarily conserved region in the CL domain of Cx50 protein, which binds Ca^2+^/CaM to mediate gap junction channel in the lens of the eye.\[[@ref25][@ref26]\] Second, the deletion was fully cosegregated with cataracts in the family but was not found in 1100 control exomes. Third, the cataract morphology of the affected members and inheritance pattern of the cataracts in the family were compatible with those of cataract caused by *GJA8* mutations. Fourth, deleteriousness evaluation with CADD supported pathogenicity of the deletion. Fifth, protein structure modeling revealed that mutant protein disrupts the structure stability of Cx50 channel.

To date, about 28 *GJA8* mutations have been reported in CC patients \[[Figure 1d](#F1){ref-type="fig"}\]. The majority of these mutations (26/28) are missense substitutes although rare cases of nonsense and frameshift mutations (2/28) have also been reported \[[Supplementary Table 4](#T7){ref-type="table"}\]. These mutations occur at the NT, TM1 to TM4, E1 and E2, or CT,\[[@ref27]\] but none has been reported on the CL domain \[[Figure 1d](#F1){ref-type="fig"} and [Supplementary Table 4](#T7){ref-type="table"}\]. No correlation between the mutation types or mutant region and the cataract phenotypes were observed. *In vitro*, functional analysis showed that these mutations triggered the formation of cataracts either through loss of normal channel functions (loss of function, altered gating, or reduced channel numbers) or gain of abnormal functions (gain of hemichannel function and formation of cytoplasmic accumulations).\[[@ref9][@ref27]\] The in-frame deletion reported here was first ever detected in the intracellular loop \[[Figure 1d](#F1){ref-type="fig"} and [Supplementary Table 4](#T7){ref-type="table"}\] and its likely pathogenicity indicated the functional importance of the deleted sequence in the Cx50 gap junction protein. The structure modeling here showed that the deletion destabilized the structure of Cx50 protein channel. Thus, it is supposed that the mutation causes cataracts in the Chinese family as a dominant-negative function mutation due to impaired function of the channel or reduced number of normal channels.

###### 

Reported connexin 50 mutants and associated cataracts

  Mutation   Amino acid change   Location   Cataract types                                                           Inheritary            Family origin   References
  ---------- ------------------- ---------- ------------------------------------------------------------------------ --------------------- --------------- -----------------------------------------
  68G\>C     R23T                NT\*       Progressive dense nuclear                                                Autosomal dominant    Iranian         Willoughby *et al*. 2003
  92T\>C     I31T                M1^†^      Nuclear cataract                                                         Autosomal dominant    Chinese         Wang *et al*. 2009
  116C\>G    T39R                M1         Cataract and microcornea and iris hypoplasia                             Autosomal dominant    Chinese         Sun *et al*. 2011
  131T\>A    V44E                M1         Cataract and microcornea                                                 Autosomal dominant    Indian          Devi and Vijayalakshmi 2006
  131T\>C    V44A                M1         Suture-sparing nuclear cataracts                                         Autosomal dominant    Chinese         Zhu *et al*. 2014
  134G\>C    W45S                M1         Jellyfish-like bilateral and microcornea                                 Autosomal dominant    Indian          Vanita *et al*. 2008b
  136G\>A    G46R                M1         Complete and microcornea                                                 Autosomal dominant    Chinese         Sun *et al*. 2011
  137 G\>T   G46V                M1         Total cataract                                                           Autosomal dominant    Pakistani       Minogue *et al*. 2009
  139G\>A    D47N                E1^‡^      Nuclear pulverulent                                                      Autosomal dominant    British         Arora *et al*. 2008; Wang *et al*. 2011
  139G\>T    D47Y                E1         Nuclear cataract                                                         Autosomal dominant    Chinese         Lin *et al*. 2008
  139G\>C    D47H                E1         Nuclear cataract                                                         Autosomal dominant    Chinese         Li *et al*. 2013
  142G\>A    E48K                E1         Zonular nuclear pulverulent                                              Autosomal dominant    Pakistani       Berry *et al*. 1999
  191T\>G    V64G                E1         Nuclear                                                                  Autosomal dominant    Chinese         Ma *et al*. 2005
  218C\>T    S73F                E1         Dense and "star-shaped," various locations in the nucleus or the poles   Autosomal dominant    Danish          Hansen *et al*. 2009
  235G\>C    V79L                M2^§^      "Full moon" Y-sutural opacity                                            Autosomal dominant    Indian          Vanita *et al*. 2006
  262C\>T    P88S                M2         Zonular pulverulent                                                      Autosomal dominant    British         Shiels *et al*. 1998
  262C\>A    P88Q                M2         Lamellar pulverulent                                                     Autosomal dominant    British         Arora *et al*. 2006
  262C\>A    P88Q                M2         "Balloon-like" Y-sutural opacities                                       Autosomal dominant    Indian          Vanita *et al*. 2008a
  264C\>T    P88T                M2         Total cataract                                                           Autosomal dominant    Chinese         Ge *et al*. 2014
  565C\>T    P189L               E2^\|\|^   Cataract and microcornea                                                 Autosomal dominant    Danish          Hansen *et al*. 2007
  593G\>A    R198Q               E2         Cataract and microcornea                                                 Autosomal dominant    Indian          Devi and Vijayalakshmi 2006
  592C\>T    R198W               E2         Cataract and microcornea                                                 Autosomal dominant    Chinese         Hu *et al*. 2010
  601G\>A    E201K               E2         Perinuclear cataracts                                                    Autosomal dominant    Chinese         Su *et al*. 2013
  670insA    203fs               E2         Cataract                                                                 Autosomal recessive   Indian          Ponnam *et al*. 2007
  773C\>T    S258F               CT^¶^      Nuclear                                                                  Autosomal dominant    Chinese         Gao *et al*. 2010
  776insG    fs                  CT         Triangular                                                               Autosomal recessive   Germany         Schmidt *et al*. 2008
  836C\>A    S259Y               CT         --                                                                       Autosomal dominant    Danish          Hansen *et al*. 2009
  827C\>T    S276F               CT         Nuclear pulverulent                                                      Autosomal dominant    Chinese         Yan *et al*. 2008
  905T\>C    L281C               CT         Lamellar/zonular                                                         Autosomal dominant    Indian          Kumar *et al*. 2011

\*Cytoplasmic amino-terminal, ^†^First transmembrane domain, ^‡^Extracellular loop 1, ^§^Second transmembrane domain, ^\|\|^Extracellular loop 2, ^¶^Cytoplasmic carboxy-terminal. NT: N-terminal; CT: C-terminal.

In recent several years, great advances have been achieved in NGS and targeted genomic enrichment technologies. The combination of these two technologies has shown considerable potential and value in clinical applications, especially in genetic diagnosis of highly heterogeneous rare genetic diseases.\[[@ref28]\] First, targeted sequencing of a small proportion of the genome (about 1/1000--1/100 of the genome) could reduce the sequencing cost to a level acceptable in clinical context. Second, the flexibility of targeted gene panel design and the availability of deep sequencing depth on NGS allow to simultaneously sequence all known genes for certain genetic disease and to comprehensively analyze SNVs, small InDels, and copy number variations at a high accurate level. Here, we performed targeted sequencing of 45 genes involved in CC (mainly in nonsyndromic CC) to explore the utility of targeted NGS sequencing for genetic diagnosis of ADCC. The high depth and completeness of sequences coverage for these 45 genes, as well as the readily identification of potential causative mutation, indicate that the targeted genes sequencing using NGS provides a tool for genetic diagnostics of nonsyndromic CC. More importantly, this method could be expanded to all CC with the addition of more CC genes in target panel.

However, a major limitation of this approach is that if the panel does not include genes responsible in tested patients, mutations will not be detected. Hence, the panel used needs to be updated when new genes are implicated in the disease. Another problem of the method is that some deep intronic mutations or mutations affecting regulatory elements may not be detected, which needs to be solved.

In conclusion, clinical molecular diagnosis of CC, particularly for ADCC, remains a challenge because of highly genetic and clinical heterogeneity. In this study, by combined NGS and targeted genomic enrichment technology, we identified a novel 15 deletion in a highly conserved region of CL domain of the *GJA8* gene associated with cataracts in a three-generation Chinese family with ADCC (mutations have never reported in CL domain before). Evidence supports a pathogenic role of the deletion in the family. More importantly, protein modeling indicates a dominant-negative impact of the deletion on the protein function. Our results demonstrate targeted genes sequencing on NGS as a useful tool for molecular diagnosis of CCs.

*Supplementary information is linked to the online version of the paper on the Chinese Medical Journal website*.
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